Marketwatch Glenmark Pharma shares jump nearly 9% on DCGI nod for clinical trials of Covid-19 tablets Admin April 30, 2020 The company said it is the first firm in India to receive such an approval from the DCGI. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
